YU108281A - Process for obtaining 2-bromo-6 beta-fluoro-pregna-1,4-diene3,20-dione-21-estra-16,17-alcohols or esters - Google Patents

Process for obtaining 2-bromo-6 beta-fluoro-pregna-1,4-diene3,20-dione-21-estra-16,17-alcohols or esters

Info

Publication number
YU108281A
YU108281A YU01082/81A YU108281A YU108281A YU 108281 A YU108281 A YU 108281A YU 01082/81 A YU01082/81 A YU 01082/81A YU 108281 A YU108281 A YU 108281A YU 108281 A YU108281 A YU 108281A
Authority
YU
Yugoslavia
Prior art keywords
diene3
pregna
estra
dione
bromo
Prior art date
Application number
YU01082/81A
Other languages
English (en)
Inventor
M Riva
L Toscano
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of YU108281A publication Critical patent/YU108281A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU01082/81A 1974-02-27 1981-04-27 Process for obtaining 2-bromo-6 beta-fluoro-pregna-1,4-diene3,20-dione-21-estra-16,17-alcohols or esters YU108281A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8928/74A GB1499822A (en) 1974-02-27 1974-02-27 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones
GB2998474 1974-07-05
GB3294574 1974-07-25
GB4998274 1974-11-19

Publications (1)

Publication Number Publication Date
YU108281A true YU108281A (en) 1982-02-28

Family

ID=27447687

Family Applications (3)

Application Number Title Priority Date Filing Date
YU01083/81A YU108381A (en) 1974-02-27 1981-04-27 Process for obtaining 2-bromo-6-fluoro-pregna-1,4-diene-3,20-dione-21-estra-17,21-cyclic ketals and acetals
YU01082/81A YU108281A (en) 1974-02-27 1981-04-27 Process for obtaining 2-bromo-6 beta-fluoro-pregna-1,4-diene3,20-dione-21-estra-16,17-alcohols or esters
YU01084/81A YU108481A (en) 1974-02-27 1981-04-27 Process for obtaning 2-bromo-6 beta-fluoro-pregna-1,4-diene-3,20-dione-21-estra-16,17-cyclic ketals and acetals

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU01083/81A YU108381A (en) 1974-02-27 1981-04-27 Process for obtaining 2-bromo-6-fluoro-pregna-1,4-diene-3,20-dione-21-estra-17,21-cyclic ketals and acetals

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU01084/81A YU108481A (en) 1974-02-27 1981-04-27 Process for obtaning 2-bromo-6 beta-fluoro-pregna-1,4-diene-3,20-dione-21-estra-16,17-cyclic ketals and acetals

Country Status (18)

Country Link
JP (1) JPS5614677B2 (no)
AR (1) AR218601A1 (no)
BE (1) BE826030A (no)
CA (1) CA1064476A (no)
CH (1) CH608243A5 (no)
DE (3) DE2508136C3 (no)
DK (1) DK144068C (no)
ES (3) ES435067A1 (no)
FI (1) FI56188C (no)
FR (1) FR2261776B1 (no)
GB (1) GB1499822A (no)
IE (1) IE42112B1 (no)
LU (1) LU71908A1 (no)
NO (1) NO144527C (no)
NZ (1) NZ176716A (no)
RO (1) RO78881A (no)
SE (1) SE410736B (no)
YU (3) YU108381A (no)

Also Published As

Publication number Publication date
NZ176716A (en) 1978-07-10
DE2533377C3 (de) 1979-08-02
RO78881A (ro) 1982-07-06
CA1064476A (en) 1979-10-16
DE2508136A1 (de) 1975-10-30
FR2261776A1 (no) 1975-09-19
IE42112L (en) 1975-08-27
DK144068B (da) 1981-11-30
DE2508136B2 (de) 1978-11-02
IE42112B1 (en) 1980-06-04
DE2533323A1 (de) 1976-02-12
BE826030A (fr) 1975-06-16
FR2261776B1 (no) 1978-07-21
NO750633L (no) 1975-08-28
SE410736B (sv) 1979-10-29
DK61575A (no) 1975-10-27
NO144527B (no) 1981-06-09
DE2533377A1 (de) 1976-02-05
DE2508136C3 (de) 1979-06-21
SE7502146L (no) 1975-08-28
FI750537A (no) 1975-08-28
NO144527C (no) 1981-09-23
CH608243A5 (en) 1978-12-29
FI56188B (fi) 1979-08-31
GB1499822A (en) 1978-02-01
DK144068C (da) 1982-05-03
DE2533377B2 (de) 1978-11-16
ES435067A1 (es) 1977-07-01
ES455933A1 (es) 1978-05-01
YU108381A (en) 1982-02-28
YU108481A (en) 1982-02-28
FI56188C (fi) 1979-12-10
ES455934A1 (es) 1978-05-01
LU71908A1 (no) 1975-06-24
JPS50126652A (no) 1975-10-04
JPS5614677B2 (no) 1981-04-06
AR218601A1 (es) 1980-06-30
DE2533323C3 (de) 1979-07-12
DE2533323B2 (de) 1978-11-16

Similar Documents

Publication Publication Date Title
YU40117B (en) Process for obtaining n-phosphonomethyglycine
CS183829B2 (en) Process for preparing thienamycine
YU82775A (en) Process for preparing new n-phenyl-n-acyl-alanine or glycinesters
YU39534B (en) Process for obtaining n-phosphono-methyl-glycine
CS187466B2 (en) Process for preparing 2-arylamino-2-imidazolines
YU44669B (en) Process for obtaining 1-carboxymethyl-5-mercaptotetrazole
YU201175A (en) Process for obtaining 1-thiadiazolylimidazolidinone
YU40631B (en) Process for obtaining substituted thiolacarbamates
CS191290B2 (en) Process for preparing aminoalkylphenyletheres
CS189730B2 (en) Process for preparing o-cyanazodyes
YU294281A (en) Process for obtaining 7-hydroxyestradiols
CS188259B2 (en) Process for preparing 2-anilinooxazoles
CS188984B2 (en) Process for preparing 3-fluorbenzodiazepines
YU104475A (en) Process for obtaining amino-2-imidazoles
YU234275A (en) Process for obtaining 6-chloro-6-chloromethyl-4-phenyl-quinazoline-3-oxide
YU247075A (en) Process for obtaining 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercapto-methyl-pyridine
CS191291B2 (en) Process for preparing 3-methylencepham-sulphoxides
YU39316B (en) Process for obtaining mono-0-beta-hydroxyethyl-7-rutosid
CS193511B2 (en) Process for preparing dihydroxy-benzenes
YU39030B (en) Process for obtaining poly-(-alkyliminoalane)
CS185239B2 (en) Process for preparing dichloracetylchloride
YU108281A (en) Process for obtaining 2-bromo-6 beta-fluoro-pregna-1,4-diene3,20-dione-21-estra-16,17-alcohols or esters
YU37375A (en) Process for obtaining new 1-aryloxy-2-hydroxy-4-sec. aminobutanes
YU125575A (en) Process for obtaining 3-cephalosporinic esters
YU186275A (en) Process for obtaining bromotetrahydrofuran